abstract |
Provided are compounds capable of modulating VCP activity. Formula (I) (R is defined herein) Or an oxide, ester, prodrug, pharmaceutically acceptable salt or solvate thereof. Such compounds can modulate VCP activity and are therefore useful in the treatment of VCP-mediated disorders such as neurodegenerative diseases. |